| Cite this article: |
| LU Yayuan,ZHAO Di,LI Ning,LU Shan,CHEN Xijing.Research advances of controlled release formulations for pulmonary delivery[J].Journal Of Pharmaceutical Research,2018,37(8):469-472,481[Click to copy] |
|
| 摘要: |
| 近年来,肺吸入制剂因为直接将药物递送至患病部位、无首过效应、患者依从性大等优点,成为研究热点。但肺吸入制剂仍然存在许多问题如药物消除迅速、给药次数频繁、存在临床用药安全性隐患。本文将从肺部主要的消除机制入手,对目前缓释肺吸入制剂进行综述,为今后肺吸入的临床应用提供思路。 |
| 关键词: 药物传递系统 肺吸入给药 药物消除机制 缓释制剂 |
| DOI:10.13506/j.cnki.jpr.2018.08.010 |
| 基金项目:国家自然科学基金项目(No.81473272、81503148) |
|
|
|
| Research advances of controlled release formulations for pulmonary delivery |
| LU Yayuan1,ZHAO Di1,LI Ning1,LU Shan2,CHEN Xijing1 |
| (1.Clinical Pharmacokinetics Laboratory,School of Basic Medicine and Clinical Pharmacy,China Pharmaceutical University,Nanjing 211198,China;2.College of Pharmacy,Hubei University of Chinese Medicine,Wuhan 430065,China) |
| Abstract: |
| In recent years,the targeted pulmonary delivery has received increasing attention,with the merit of direct drug deposition at the diseased site,lack of first pass metabolism and good compliance of patients.However,it is strictly challenged in many different ways such as the efficient clearance mechanisms,frequent dosing and clinical medication safety problem.This review covered these controlled release formulations for the clinical application of pulmonary delivery, based on lung clearance mechanisms. |
| Key words: Drug delivery system Pulmonary drug delivery Clearance mechanisms Controlled release formulations |